Project Grant H75DP004180

Federal Cooperative Agreement Summary The University of North Carolina at Chapel Hill received a $1.9 million Cooperative Agreement award dated July 30, 2025, from the National Heart, Lung, and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct the PREEMPT (Prospective Randomized Evaluation and Management of Premature Atherosclerosis) study. This seven-year research initiative, extending through June 30, 2032, will develop and evaluate optimal...

This $783,801 Project Grant, awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) on September 3, 2025, supports research to demonstrate the feasibility of democratizing cardiac magnetic resonance imaging (CMR) technology for use in community family health centers. The award, which extends through May 31, 2029, funds development and implementation of an automated, push-button CMR protocol (AutoCMR) combined with...

Federal Project Grant Award Summary Michigan Technological University received a $589,998 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025, through August 31, 2028. The award funds research investigating cardiac sensory and sympathetic nerve dysregulation in hypertrophic cardiomyopathy (HCM), a genetic heart disease affecting approximately 1 in 500 individuals and representing...

Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the Regents of the University of Michigan a $942,143 Project Grant (CFDA 93.837: Cardiovascular Diseases Research) on September 25, 2025, to evaluate the implementation of the World Health Organization's HEARTS (Hypertension and Diabetes) Technical Package within Guatemala's Ministry of Health primary care system. The research addresses a critical global health challenge, as approximately 80% of individuals...

This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $742,395 to Case Western Reserve University (CWRU) to develop and validate a machine learning-based analysis of coronary artery calcium scans (CTCS) to identify biomarkers for predicting heart failure risk. The 4-year project aims to create an automated tool for extracting CTCS-derived radiomics, develop a comprehensive heart failure risk...

Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $130,065 Project Grant on July 10, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to The Regents of the University of California, San Francisco. The award supports the REMOTE-BP (Research and Mentorship for Optimizing Treatment and Evaluation of Blood Pressure) initiative, which conducts systematic economic analyses of remote team-based hypertension care delivery models implemented...

Federal Project Grant Award Summary The University of Michigan's Regents, through its Office of Research and Sponsored Projects, received a $207,342 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 12, 2025, with completion targeted for June 30, 2030. The award establishes the Michigan Emergency Medicine Physician-Scientist STARR (Specialized Training And Research in Residency)...

Federal Project Grant Award Summary Vanderbilt University Medical Center received a $186,065 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 22, 2025, with completion targeted for August 31, 2030. Under the principal direction of Dr. Debra Dixon, an instructor at VUMC, this award supports career development and research activities designed to reduce heart failure incidence and mortality...

Federal Grant Award Summary Cleveland Clinic Lerner College of Medicine of Case Western Reserve University received a $362,250 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025, through July 31, 2027. This pilot study, titled "Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Impacts Patient Outcomes: The ACT-BP Pilot," will develop and test...

Federal Project Grant Award Summary The University of Chicago received a $686,906 Project Grant awarded on April 17, 2026, under the National Institute for Minority Health and Health Disparities (NIMHD) Minority Health and Health Disparities Research program (CFDA 93.307). The grant supports the development of a Community Out-of-Hospital Cardiac Arrest (OHCA) Risk Prediction framework using machine learning and artificial intelligence to address geographic and temporal variability in cardiac...